BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Ischemia
,
Leukocyte
,
Metabolism of nitric oxide
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
amyloid β- peptide
Summary
General Info
Curated Studies
Most Correlated Studies
Islets of langerhans from organ donors without diabetes/metabolic disorders exposed to IL1b and IFNg
C. elegans young adult stage treated with 13L cocoa peptide
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of β-aminopyrrolidine containing peptides as β-amyloid aggregation inhibitors for Alz…
Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer's disease br…
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation…
Degradation of FA reduces Aβ neurotoxicity and Alzheimer-related phenotypes.
Cross-Linked Amyloid β-Protein Oligomers: A Missing Link in Alzheimer's Disease Pathology?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Molecular Imaging of Primary Amyloid Cardiomyopathy
Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
SNIFF - 3-Week Aptar CPS Device
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ